IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
Open | $0.81 |
Close | $0.80 |
Volume / Avg. | 57.57K / 559.62K |
Day Range | 0.79 - 0.81 |
52 Wk Range | 0.65 - 2.48 |
Market Cap | $35.23M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 1.48% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of IN8bio (NASDAQ:INAB) through any online brokerage.
Other companies in IN8bio’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).
There is no analysis for IN8bio.
IN8bio has a consensus price target of $9.19.
The stock price for IN8bio (NASDAQ: INAB) is $0.7985 last updated July 3, 2024 at 1:24 PM EDT.
There are no upcoming dividends for IN8bio.
IN8bio’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for IN8bio.
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.